Clinicopathlogical features and prognosis of drug rash with eosinophilia and systemic symptoms: A study of 30 cases in Taiwan

Journal of the European Academy of Dermatology and Venereology

Volumn 22, Issue 9, 2008, Pages 1044-1049

  Chiou, C C ^b   Yang, L C ^b   Hung, S I ^c   Chang, Y C ^b   Kuo, T T ^b   Ho, H C ^b   Hu, S ^b   Hong, H S ^b   Chung, W H ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Adverse drug reaction; Drug hypersensitivity syndrome; Eosinophilia

Indexed keywords

ALLOPURINOL; AMOXICILLIN; CARBAMAZEPINE; CIPROFLOXACIN; DAPSONE; DICLOFENAC; HYDROCORTISONE; IBUPROFEN; INDOMETACIN; LEVAMISOLE; MEROPENEM; METRONIDAZOLE; PHENYTOIN; PREDNISOLONE; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD DYSCRASIA; CLINICAL ARTICLE; CLINICAL FEATURE; DEMOGRAPHY; DISEASE COURSE; DRESS SYNDROME; ERYTHEMA MULTIFORME; FEMALE; HUMAN; HUMAN HERPESVIRUS 6; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; LATENT PERIOD; LICHENOID ERUPTION; LIVER DYSFUNCTION; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PSEUDOLYMPHOMA; SEROLOGY; SEX RATIO; SYMPTOM; TAIWAN; TREATMENT OUTCOME; VASCULITIS; VIRUS REACTIVATION; CHEMICALLY INDUCED DISORDER; EOSINOPHILIA; MIDDLE AGED; PATHOLOGY; RASH;

ADOLESCENT; ADULT; AGED; ALLOPURINOL; CARBAMAZEPINE; EOSINOPHILIA; EXANTHEMA; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PREDNISOLONE; PROGNOSIS; TAIWAN; TREATMENT OUTCOME;

EID: 49649122483     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2008.02585.x     Document Type: Article

References (16)

1. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998 279 : 1200 1205.
2. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994 331 : 1272 1285.
3. Wolf R, Matz H, Marcos B, Orion E. Drug rash with eosinophilia and systemic symptoms vs toxic epidermal necrolysis: the dilemma of classification. Clin Dermatol 2005 23 : 311 314.
4. Descamps V, Valance A, Edlinger C et al. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol 2001 137 : 301 304.
5. Wolf R, Orion E, Marcos B, Matz H. Life-threatening acute adverse cutaneous drug reactions. Clin Dermatol 2005 23 : 171 181.
6. Arellano F, Sacristan JA. Allopurinol hypersensitivity syndrome: a review. Ann Pharmacother 1993 27 : 337 343.
7. Roujeau JC. Clinical heterogeneity of drug hypersensitivity. Toxicology 2005 209 : 123 129.
8. Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981 30 : 239 245.
9. Schlienger RG, Shear NH. Antiepileptic drug hypersensitivity syndrome. Epilepsia 1998 39 : S3 S7.
10. Hung SI, Chung WH, Liou LB et al. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci USA 2005 102 : 4134 4139.
11. Shear NH, Spielberg SP. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J Clin Invest 1988 82 : 1826 1832.
12. Cheriyan S, Patterson R, Greenberger PA, Grammer LC, Latall J. The outcome of Stevens-Johnson syndrome treated with corticosteroids. Allergy Proc 1995 16 : 151 155.
13. Roujeau JC. Drug-induced toxic epidermal necrolysis II. Current aspects. Clin Dermatol 1993 11 : 493 500.
14. Tas S, Simonart T. Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update. Dermatology 2003 206 : 353 356.
15. Chiou CC, Chung WH, Hung SI, Yang LC, Hong HS. Fulminant type 1 diabetes mellitus caused by drug hypersensitivity syndrome with human herpesvirus 6 infection. J Am Acad Dermatol 2006 54 : S14 S17.
16. Callot V, Roujeau JC, Bagot M et al. Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities. Arch Dermatol 1996 132 : 1315 1321.